Literature DB >> 19644491

Gene therapy continues to mature and to face challenges.

David A Williams.   

Abstract

Mesh：

Year:  2009        PMID： 19644491      PMCID： PMC2835244          DOI： 10.1038/mt.2009.162

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  1 in total

1.  Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.

Authors:  Martin A Pule; Barbara Savoldo; G Doug Myers; Claudia Rossig; Heidi V Russell; Gianpietro Dotti; M Helen Huls; Enli Liu; Adrian P Gee; Zhuyong Mei; Eric Yvon; Heidi L Weiss; Hao Liu; Cliona M Rooney; Helen E Heslop; Malcolm K Brenner
Journal:  Nat Med       Date:  2008-11-02       Impact factor: 53.440
  1 in total
  9 in total

Review 1.  Hybrid lentiviral vectors.

Authors:  Waseem Qasim; Conrad A Vink; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-04-20       Impact factor: 11.454

2.  When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

3.  Ectopic platelet-delivered factor (F) VIII for the treatment of Hemophilia A: Plasma and platelet FVIII, is it all the same?

Authors:  Teshell K Greene; Michele P Lambert; Mortimer Poncz
Journal:  J Genet Syndr Gene Ther       Date:  2011-11-12

4.  Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.

Authors:  Naoya Uchida; Kareem N Washington; Coen J Lap; Matthew M Hsieh; John F Tisdale
Journal:  Mol Ther       Date:  2010-10-12       Impact factor: 11.454

5.  Sustained expression of insulin by a genetically engineered sertoli cell line after allotransplantation in diabetic BALB/c mice.

Authors:  Gurvinder Kaur; Lea Ann Thompson; Mithun Pasham; Kim Tessanne; Charles R Long; Jannette M Dufour
Journal:  Biol Reprod       Date:  2014-04-02       Impact factor: 4.285

6.  Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.

Authors:  Marco Andreani; Manuela Testi; Javid Gaziev; Rossella Condello; Andrea Bontadini; Pier Luigi Tazzari; Francesca Ricci; Lidia De Felice; Francesca Agostini; Daniela Fraboni; Giuliana Ferrari; Mariarosa Battarra; Maria Troiano; Pietro Sodani; Guido Lucarelli
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

7.  Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients.

Authors:  Emanuela Anna Roselli; Riccardo Mezzadra; Marta Claudia Frittoli; Giulietta Maruggi; Erika Biral; Fulvio Mavilio; Fabrizio Mastropietro; Antonio Amato; Giovanni Tonon; Chiara Refaldi; Maria Domenica Cappellini; Marco Andreani; Guido Lucarelli; Maria Grazia Roncarolo; Sarah Marktel; Giuliana Ferrari
Journal:  EMBO Mol Med       Date:  2010-08       Impact factor: 12.137

8.  Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy.

Authors:  Gurvinder Kaur; Charles R Long; Jannette M Dufour
Journal:  Spermatogenesis       Date:  2012-01-01

9.  Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice.

Authors:  Gurvinder Kaur; Lea Ann Thompson; Rachel L Babcock; Karl Mueller; Jannette M Dufour
Journal:  DNA Cell Biol       Date:  2018-06-21       Impact factor: 3.311
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.